Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1980-4-17
|
pubmed:abstractText |
Clearance of 0-100 mg/L concentrations of galactose from the blood depends on nutrient hepatic blood flow. We can measure such concentrations, which was not previously possible, by a continuous-flow method involving the use of galactose oxidase and peroxidase, the latter being coupled to a fluorogenic substrate, p-hydroxyphenylacetic acid. Interfering substances in the peroxidase reaction are removed by zinc/alkali precipitation. Sensitivity is maximized by using saturating concentrations of the enzymes and substrate. In prepared plasma test samples with galactose concentrations of 10, 40, 70, and 100 mg/L, the within-run CV's ranged from 2.1 to 8.6%, and day-to-day CV's from 2.2 to 17.2%, the largest CV's being for the 10 mg/L concentration. Normal subjects are shown to clear galactose more efficiently than subjects with moderate cirrhosis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0009-9147
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
282-5
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:7353277-Anticoagulants,
pubmed-meshheading:7353277-Fluorometry,
pubmed-meshheading:7353277-Galactose,
pubmed-meshheading:7353277-Galactosemias,
pubmed-meshheading:7353277-Humans,
pubmed-meshheading:7353277-Liver,
pubmed-meshheading:7353277-Liver Cirrhosis,
pubmed-meshheading:7353277-Regional Blood Flow,
pubmed-meshheading:7353277-Specimen Handling
|
pubmed:year |
1980
|
pubmed:articleTitle |
Continuous-flow fluorometry of low galactose concentrations in blood or plasma.
|
pubmed:publicationType |
Journal Article
|